• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 miRNA 表达与基底细胞癌亚型的相关性。

Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.

出版信息

G3 (Bethesda). 2012 Feb;2(2):279-86. doi: 10.1534/g3.111.001115. Epub 2012 Feb 1.

DOI:10.1534/g3.111.001115
PMID:22384406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3284335/
Abstract

Basal cell carcinomas (BCCs) are the most common cancers in the United States. The histologic appearance distinguishes several subtypes, each of which can have a different biologic behavior. In this study, global miRNA expression was quantified by high-throughput sequencing in nodular BCCs, a subtype that is slow growing, and infiltrative BCCs, aggressive tumors that extend through the dermis and invade structures such as cutaneous nerves. Principal components analysis correctly classified seven of eight infiltrative tumors on the basis of miRNA expression. The remaining tumor, on pathology review, contained a mixture of nodular and infiltrative elements. Nodular tumors did not cluster tightly, likely reflecting broader histopathologic diversity in this class, but trended toward forming a group separate from infiltrative BCCs. Quantitative polymerase chain reaction assays were developed for six of the miRNAs that showed significant differences between the BCC subtypes, and five of these six were validated in a replication set of four infiltrative and three nodular tumors. The expression level of miR-183, a miRNA that inhibits invasion and metastasis in several types of malignancies, was consistently lower in infiltrative than nodular tumors and could be one element underlying the difference in invasiveness. These results represent the first miRNA profiling study in BCCs and demonstrate that miRNA gene expression may be involved in tumor pathogenesis and particularly in determining the aggressiveness of these malignancies.

摘要

基底细胞癌(BCC)是美国最常见的癌症。组织学表现可区分出几种亚型,每种亚型的生物学行为可能不同。在这项研究中,通过高通量测序对结节性 BCC(生长缓慢的一种亚型)和侵袭性 BCC(通过真皮扩散并侵犯皮肤神经等结构的侵袭性肿瘤)进行了全局 miRNA 表达定量。基于 miRNA 表达,主成分分析正确地对八种侵袭性肿瘤中的七种进行了分类。其余的肿瘤在病理检查中包含了结节性和侵袭性成分的混合物。结节性肿瘤没有紧密聚集,可能反映了该类别的更广泛的组织病理学多样性,但倾向于形成一个与侵袭性 BCC 分开的组。针对在 BCC 亚型之间表现出显著差异的六个 miRNA 开发了定量聚合酶链反应(qPCR)检测,其中五个在侵袭性和三个结节性肿瘤的复制组中得到了验证。miR-183 是一种在多种恶性肿瘤中抑制侵袭和转移的 miRNA,其在侵袭性肿瘤中的表达水平始终低于结节性肿瘤,这可能是侵袭性差异的一个因素。这些结果代表了 BCC 中首次 miRNA 分析研究,并表明 miRNA 基因表达可能参与肿瘤发病机制,特别是决定这些恶性肿瘤的侵袭性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/a6ed5277e0fd/279f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/cb207569609d/279f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/6ee30ef59b8b/279f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/02e5d1ff7d32/279f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/a6ed5277e0fd/279f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/cb207569609d/279f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/6ee30ef59b8b/279f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/02e5d1ff7d32/279f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7126/3284335/a6ed5277e0fd/279f4.jpg

相似文献

1
Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.全球 miRNA 表达与基底细胞癌亚型的相关性。
G3 (Bethesda). 2012 Feb;2(2):279-86. doi: 10.1534/g3.111.001115. Epub 2012 Feb 1.
2
Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.p16 蛋白在皮肤基底细胞癌中的表达:仍远未被充分理解。
Acta Dermatovenerol Croat. 2020 Jul;28(1):43-44.
3
Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.钙调蛋白在皮肤基底细胞癌中的免疫组化表达
Acta Dermatovenerol Croat. 2015;23(4):254-9.
4
Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas.Bmi-1、CK15、Bcl-2在不同类型基底细胞癌中的免疫表达。
Postepy Dermatol Alergol. 2022 Oct;39(5):980-985. doi: 10.5114/ada.2022.120888. Epub 2022 Nov 9.
5
bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.侵袭性和非侵袭性基底细胞癌中bcl-2蛋白的表达
J Cutan Pathol. 2000 Jul;27(6):283-91. doi: 10.1034/j.1600-0560.2000.027006283.x.
6
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.COL10A1 的表达可将高危基底细胞癌基质中存在的一小部分癌相关成纤维细胞区分开来。
Br J Dermatol. 2024 Oct 17;191(5):775-790. doi: 10.1093/bjd/ljae258.
7
Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.微结节性基底细胞癌:一种独特的亚型?与结节性和浸润性基底细胞癌的关系。
J Dermatol. 2010 Jul;37(7):611-6. doi: 10.1111/j.1346-8138.2009.00772.x.
8
Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.具有混合组织形态学的皮肤基底细胞癌:一项比较研究
Cesk Patol. 2016 Fall;52(4):222-226.
9
Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma.用于识别基底细胞癌侵袭性组织学亚型的临床和皮肤镜因素
Front Oncol. 2021 Feb 19;10:630458. doi: 10.3389/fonc.2020.630458. eCollection 2020.
10
Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.人皮肤基底细胞癌中P120连环蛋白表达的研究
Acta Medica (Hradec Kralove). 2017;60(1):32-36. doi: 10.14712/18059694.2017.48.

引用本文的文献

1
miRNA: The Next Frontier in Dermatology Research and Therapeutics.微小RNA:皮肤病学研究与治疗的新前沿
Indian J Dermatol. 2024 Nov-Dec;69(6):486. doi: 10.4103/ijd.ijd_568_23. Epub 2024 Oct 29.
2
Contribution of Keratinocytes in Skin Cancer Initiation and Progression.角质形成细胞在皮肤癌发生和进展中的作用。
Int J Mol Sci. 2024 Aug 13;25(16):8813. doi: 10.3390/ijms25168813.
3
Biomarkers in Cutaneous Keratinocyte Carcinomas.皮肤角质形成细胞癌中的生物标志物

本文引用的文献

1
Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.前列腺癌中小非编码 RNA 转录组的诊断和预后特征。
Oncogene. 2012 Feb 23;31(8):978-91. doi: 10.1038/onc.2011.304. Epub 2011 Jul 18.
2
MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.散发性和遗传性髓样甲状腺癌的 microRNA 图谱分析鉴定了淋巴结转移、预后的预测因子和潜在的治疗靶点。
Clin Cancer Res. 2011 Jul 15;17(14):4772-81. doi: 10.1158/1078-0432.CCR-11-0242. Epub 2011 May 27.
3
MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Dermatol Ther (Heidelb). 2024 Aug;14(8):2039-2058. doi: 10.1007/s13555-024-01233-w. Epub 2024 Jul 20.
4
MicroRNA Signatures Associated with Basal Cell Carcinoma Subtypes.与基底细胞癌亚型相关的微小RNA特征
JID Innov. 2024 May 3;4(4):100286. doi: 10.1016/j.xjidi.2024.100286. eCollection 2024 Jul.
5
Does the histopathological subtype of primary basal cell carcinoma predict the subtype of secondary tumours? What role do genetic mutations play?原发性基底细胞癌的组织病理学亚型能否预测继发性肿瘤的亚型?基因突变起什么作用?
Skin Health Dis. 2022 May 18;3(2):e123. doi: 10.1002/ski2.123. eCollection 2023 Apr.
6
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.PD-1 抑制在治疗局部晚期或转移性基底细胞癌中的临床活性。
J Immunother Cancer. 2022 May;10(5). doi: 10.1136/jitc-2022-004839.
7
Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?miRNA 调控是否是控制非黑素瘤皮肤癌演进的关键?
Genes (Basel). 2021 Nov 29;12(12):1929. doi: 10.3390/genes12121929.
8
Novel alterations in IFT172 and KIFAP3 may induce basal cell carcinoma.IFT172 和 KIFAP3 中的新突变可能会引发基底细胞癌。
Orphanet J Rare Dis. 2021 Oct 21;16(1):443. doi: 10.1186/s13023-021-02033-7.
9
IsomiR_Window: a system for analyzing small-RNA-seq data in an integrative and user-friendly manner.异源微小RNA窗口:一种以综合且用户友好的方式分析小RNA测序数据的系统。
BMC Bioinformatics. 2021 Feb 1;22(1):37. doi: 10.1186/s12859-021-03955-6.
10
Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.基底细胞癌:从病理生理学到新型治疗方法
Biomedicines. 2020 Oct 23;8(11):449. doi: 10.3390/biomedicines8110449.
微小 RNA-200a 通过靶向 E-钙黏蛋白抑制子 ZEB2 抑制 CD133/1+ 卵巢癌干细胞的迁移和侵袭。
Gynecol Oncol. 2011 Jul;122(1):149-54. doi: 10.1016/j.ygyno.2011.03.026. Epub 2011 May 6.
4
MicroRNA expression signatures of bladder cancer revealed by deep sequencing.深度测序揭示膀胱癌的 microRNA 表达特征。
PLoS One. 2011 Mar 28;6(3):e18286. doi: 10.1371/journal.pone.0018286.
5
Cutaneous malignancies: melanoma and nonmelanoma types.皮肤恶性肿瘤:黑素瘤和非黑素瘤类型。
Plast Reconstr Surg. 2011 Mar;127(3):37e-56e. doi: 10.1097/PRS.0b013e318206352b.
6
MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.MicroRNA-21 靶向肿瘤抑制基因 ANP32A 和 SMARCA4。
Oncogene. 2011 Jun 30;30(26):2975-85. doi: 10.1038/onc.2011.15. Epub 2011 Feb 14.
7
MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma.微小 RNA-141 通过靶向 YAP1 赋予人食管鳞癌细胞对顺铂诱导凋亡的抗性。
J Hum Genet. 2011 Apr;56(4):270-6. doi: 10.1038/jhg.2011.1. Epub 2011 Feb 3.
8
Accurate molecular classification of kidney cancer subtypes using microRNA signature.利用 microRNA 特征进行肾癌亚型的准确分子分类。
Eur Urol. 2011 May;59(5):721-30. doi: 10.1016/j.eururo.2011.01.004. Epub 2011 Jan 13.
9
Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers.基底细胞癌:起源细胞、癌症干细胞假说和干细胞标志物。
Br J Dermatol. 2011 Apr;164(4):696-711. doi: 10.1111/j.1365-2133.2010.10158.x. Epub 2011 Mar 16.
10
miRNAs in human cancer.miRNAs 与人类癌症。
J Pathol. 2011 Jan;223(2):102-15. doi: 10.1002/path.2806. Epub 2010 Nov 18.